P18.05 Immunotherapy Beyond First-Line in NSCLC, Still An Option
| Autor: | Modrego, A., Bote, H., Jimenez-Aguilar, E., Ponce-Aix, S., Zugazagoitia, J., Baena, J., Mazarico, J.M., Nuñez, J.A., Iglesias, L.C., Paz-Ares, L. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S354-S355 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|